AskaPatient.com

Our website has more than 100k patient reviews for medications A-Z. Learn about drugs and treatments in our newsletter:

[AskaPatient.com @AskaPatient]

@BlueJ11274903 @HerbsandDirt Thank you BlueJ for the recommendation! Here's the Ozempic experiences direct link:
https://t.co/v6BIY7JMDL

[AskaPatient.com @AskaPatient]

Read more about which meds are discontinued and possible reasons why, including decrease in Rxs
https://t.co/fgi8jPxaat

[AskaPatient.com @AskaPatient]

All Cephalon TIRF (Transmucosal Immediate-Release Fentanyl) meds will be discontinued September 30. Sign up for our Drug Safety Updates newsletter for a September 1 update on this development.
https://t.co/AjIe9X8Qtd

[AskaPatient.com @AskaPatient]

As of Aug 28, no new patients can sign up to receive Cephalon’s Transmucosal Immediate-Release Fentanyl (TIRF) meds for breakthrough cancer pain, such as Actiq lozenge or Fentora buccal tablets or fentanyl citrate (all made by Cephalon).@PainNewsNetwork https://t.co/YJf62JJR3v

[AskaPatient.com @AskaPatient]

@GianlucaSgueo For medical websites used by consumers, we found some (not too many) sites that disclose that they use #AI-generated content. Is disclosure enough or is more level of detail about sources required for trust? Seems that more detail is needed for trust.
https://t.co/ZmMFdh0eHo

[AskaPatient.com @AskaPatient]

It's 2033. You might receive cancer treatment using nanorobots. Our recent post explains how it works.
https://t.co/5YJbEvWjAi

[AskaPatient.com @AskaPatient]

May 28, 2023: Five new drug approvals; FDA flags ADHD drugs with safety updates; Antibiotics research; Pancreatic cancer study; Brain-Computer technology; Allergy drug side effect, by @AskaPatient https://t.co/g33XneM0q6

[AskaPatient.com @AskaPatient]

Read "Drugs & Treatments News" on Veozah Rx for hot flashes; OTC potential for oral contraceptive Opill; Mozilla reviews privacy of health apps; preventing hypothyroidism; metformin for longer life; cancer and immunotherapy. https://t.co/d7dvPWSPlw

[AskaPatient.com @AskaPatient]

Do you think this birth control pill should be available over-the-counter in the U.S.? Answer our quick poll and see what others think.
https://t.co/aCw019uhWw

[AskaPatient.com @AskaPatient]

Check out how @nyugrossman researchers discovered why hair goes gray. As the process of growing hair repeats itself over and over again as we age, melanocyte stem cells (needed for hair color) eventually get stuck in the "wrong" place.
https://t.co/tBMlJYLPJZ

[AskaPatient.com @AskaPatient]

More news: Safety label update for seizure med Carbatrol; FDA ramps up opioid warnings; contraceptives and breast cancer study; premature menopause; comparing BP meds; Public Citizen Health Resource Group updates Toujeo diabetes drug to "limited use."
https://t.co/IJQL1uUfcx

[AskaPatient.com @AskaPatient]

Read our "Drugs & Treatments News" on Nurtec packaging; Zavzpre nasal spray for migraine; research on apremilast (Otezla) for curbing alcohol use; Nexletol - heart study; reality-check case study on Ozempic for Type 2: it takes work. https://t.co/GL3bGooVZQ

[AskaPatient.com @AskaPatient]

In our April 2 "Ask a Patient® Health News: Drugs & Treatments: Drugs for rare skin cancer, eczema; label changes for Hyzaar, Fetzima, Vuity; ADHD stimulant use, overdiagnosis; the state of chronic pain treatment; cancer immunotherapy; allergy tips
https://t.co/uZFtATNF3E

[AskaPatient.com @AskaPatient]

In our March 5 "Ask a Patient® Health News: Drugs & Treatments:" Syfovre approved for AMD; safety updates for Depakote; Restasis, Sovaldi, Farxiga, Jardiance as first-time generics; AGGA device debacle; antidepressant tapering; rehab after heart attack.
https://t.co/OFvJdr5SJ3

[AskaPatient.com @AskaPatient]

Check out our Feb. 19 "Ask a Patient® Health News: Drugs & Treatments" for safety updates for Xarelto and Epipen; new (and unusual) constipation treatment; allergy drug causing itching; eyedrops for myopia in children; colon cancer and pomegranate study.
https://t.co/2TmNbS2LoH

[AskaPatient.com @AskaPatient]

Our Feb. 5 Drugs & Treatments News includes new approvals for breast cancer and diabetes drugs, the right diet to combat depression, overseas pharma manufacturing inspections, penicillin allergy tips, new Amazon RxPass and OptumRx Price Edge pharmacy plans
https://t.co/RgUb2asUMo

[AskaPatient.com @AskaPatient]

Check out our inaugural "Drugs and Treatments" newsletter of 2023 for: Notable new drugs of 2022; FDA label changes; Heart failure drug review; research on water pills study, diet and epilepsy, AMD and vitamin supplements, and clonidine for PTSD.
https://t.co/dekin3r4Ca

[AskaPatient.com @AskaPatient]

https://t.co/QmIVMbaDVw

[AskaPatient.com @AskaPatient]

Labiotech interviewed Paul Feurstadt, director of non-inflammatory bowel disease research at GastroCenterCT to find out why Rebyota (the first FDA-approved fecal microbiota product) is causing a stir in the field.
https://t.co/vINYpUZjsC

[AskaPatient.com @AskaPatient]

Have you ever had trouble discontinuing a medication? If so, which was the most problematic? An antidepressant, GERD, ADHD, pain, allergy drug, or something else? Answer our quick poll! https://t.co/aCw019LSO4